1.Dorian, P, Cass, D, Schwartz, B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002;346:884–90.
2.Kudenchuk, PJ, Cobb, LA, Copass, MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871–8.
3.Longstreth, WT Jr, Diehr, P, Inui, TS.Prediction of awakening after out-of-hospital cardiac arrest. N Engl J Med 1983;308:1378–82.
4.Levy, DE, Caronna, JJ, Singer, BH, et al. Predicting outcome from hypoxic-ischemic coma. JAMA 1985;253:1420–6.
5.Scollo-Lavizzari, G, Bassetti, C.Prognostic value of EEG in post-anoxic coma after cardiac arrest. Eur Neurol 1987;26:161–70.
6.Brunko, E, Zegers de Beyl, D.Prognostic value of early cortical somatosensory evoked potentials after resuscitation from cardiac arrest. Electroencephalogr Clin Neurophysiol 1987;66:15–24.
7.Madl, C, Grimm, G, Kramer, L, et al. Early prediction of individual outcome after cardiopulmonary resuscitation. Lancet 1993;341:855–8.
8.Morimoto, Y, Kemmotsu, O, Kitami, K, et al. Acute brain swelling after out-of-hospital cardiac arrest: pathogenesis and outcome. Crit Care Med 1993;21:104–10.
9.Rupright, J, Woods, EA, Singh, A.Hypoxic brain injury: evaluation by single photon emission computed tomography. Arch Phys Med Rehabil 1996;77:1205–8.
10.Vaagenes, P, Mullie, A, Fodstad, DT, et al. The use of cytosolic enzyme increase in cerebrospinal fluid of patients resuscitated after cardiac arrest. Brain Resuscitation Clinical Trial I Study Group. Am J Emerg Med 1994;12:621–4.
11.Karkela, J, Pasanen, M, Kaukinen, S, et al. Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate. Crit Care Med 1992;20:378–86.
12.Hans, P, Bonhomme, V, Collette, J, et al. Neuron-specific enolase as a marker of in vitro neuronal damage. Part I: Assessment of neuron-specific enolase as a quantitative and specific marker of neuronal damage. J Neurosurg Anesthesiol 1993;5:111–6.
13.Marangos, PJ, Schmechel, DE.Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci 1987;10:269–95.
14.Steinberg, R, Gueniau, C, Scarna, H, et al. Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage. J Neurochem 1984;43:19–24.
15.Schmechel, D, Marangos, PJ, Zis, AP, et al. Brain enolases as specific markers of neuronal and glial cells. Science 1978;199:313–5.
16.Schmechel, D, Marangos, PJ, Brightman, M.Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978;276:834–6.
17.Schoerkhuber, W, Kittler, H, Sterz, F, et al. Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 1999;30:1598–603.
18.Persson, L, Hardemark, HG, Gustafsson, J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987;18:911–8.
19.Schaarschmidt, H, Prange, HW, Reiber, H.Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 1994;25:558–65.
20.Mabe, H, Suzuki, S, Mase, M, et al. Serum neuron-specific enolase levels after subarachnoid hemorrhage. Surg Neurol 1991;36:170–4.
21.Barone, FC, Clark, RK, Price, WJ, et al. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res 1993;623:77–82.
22.Cunningham, RT, Watt, M, Winder, J, et al. Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest 1996;26:298–303.
23.Martens, P, Raabe, A, Johnsson, P.Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998;29:2363–6.
24.Dauberschmidt, R, Zinsmeyer, J, Mrochen, H, et al. Changes of neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation. Mol Chem Neuropathol 1991;14:237–45.
25.Fogel, W, Krieger, D, Veith, M, et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 1997;25:1133–8.
26.Bassetti, C, Bomio, F, Mathis, J, et al. Early prognosis in coma after cardiac arrest: a prospective clinical, electrophysiological, and biochemical study of 60 patients. J Neurol Neurosurg Psychiatry 1996;61:610–5.
27.Herrmann, M, Ebert, AD, Galazky, I, et al. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke 2000;31:645–50.
28.Jennett, B, Bond, M.Assessment of outcome after severe brain damage. Lancet 1975;1:480–4.
29.Koller-Strametz, J, Fritzer, M, Gwechenberger, M, et al. Elevation of prostate-specific markers after cardiopulmonary resuscitation. Circulation 2000;102:290–3.
30.Jacobs, P, Noseworthy, TW.National estimates of intensive care utilization and costs: Canada and the United States. Crit Care Med 1990;18:1282–6.
31.Martens, P, Haymerle, A, Sterz, F, et al. Limitation of life support after resuscitation from cardiac arrest: practice in Belgium and Austria. Resuscitation 1997;35:123–8.
32.Stelzl, T, von Bose, MJ, Hogl, B, et al. A comparison of the prognostic value of neuron-specific enolase serum levels and somatosensory evoked potentials in 13 reanimated patients. Eur J Emerg Med 1995;2:24–7.
33.Burghuber, OC, Worofka, B, Schernthaner, G, et al. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 1990;65:1386–90.
34.Zeltzer, PM, Marangos, PJ, Evans, AE, et al. Serum neuron-specific enolase in children with neuroblastoma: relationship to stage and disease course. Cancer 1986;57:1230–4.
35.D’Alessandro, M, Mariani, P, Lomanto, D, et al. Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors. Tumour Biol 1992;13:352–7.